Agios Pharmaceuticals (AGIO) Q2 2026 Earnings

Apr 29Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.95
-1.87
-1.78
-1.69

Details

Expected EPS
-1.803397
Actual EPS
-1.69
Surprise EPS
0.11
Surprise Percent
+6.29%

Description

⁨Agios Pharmaceuticals⁩ (⁦AGIO⁩) has reported earnings of ⁦-1.69⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts